10 Year Financial Data of PSS World Medical, Inc. (PSSI)

0 (1y: -100%)

Market Cap	1.46 B	P/E(ttm)	11.00
Enterprise Value	1.7 B	P/B	2.04

PSSI- NAS (USA)
PSS World Medical, Inc.

Currently 3.5/5

Business Predictability Rank: 3.5-Star
Back Testing Results:
Average gain of all 3.5-Star stocks: 9.3% per year.
% of Stocks that are in still loss if held for 10yrs: 9%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$0.00

2 Medium Warning Signs 5 Good Signs

Bookmark

Annual Rates (per share)	10 yrs*	5 yrs*	12 months*
Revenue Growth (%)	9.7	8.5	9.2
EBITDA Growth (%)	18.6	16.2	8.3
Free Cash Flow Growth (%)	44.9	27.4	12.9
Book Value Growth (%)	9.6	11.2	-7.5

*12-month growth rate is calculated with the per share revenue (EBITDA, FCF, earnings) of the last 12 months over the per share revenue (EBITDA, FCF, earnings) over the previous 12 months. 5-year and 10-year growth rates are calculated with least-square regression based on the 5-year and 10-year numbers.

Trendline:

Export:

Print This Table Print

See this page for the explanation of the data and charts * All numbers are in millions except for per share data

Per Share Data	Annuals											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	TTM	Sep11	Dec11	Mar12	Jun12	Sep12

Revenue per Share ($)	16.74	19.85	22.46	24.15	25.12	28.04	32.17	34.87	35.98	38.93	36.93	9.67	10.06	10.33	8.14	8.40
EBITDA per Share	0.59	0.95	1.25	1.40	1.54	1.78	2.08	2.51	2.92	3.13	2.98	0.83	0.83	0.87	0.58	0.70
Free Cashflow per Share	0.46	0.01	0.16	0.76	0.67	0.76	1.03	1.30	1.73	1.93	1.85	0.30	0.03	1.07	0.38	0.37
Earnings per Share ($)	-0.78	0.40	0.59	0.66	0.73	0.86	0.96	1.18	1.32	1.38	1.27	0.37	0.38	0.38	0.21	0.30
Book Value per Share	3.48	3.52	4.22	5.20	5.49	5.06	5.71	6.92	7.83	7.17	8.14	7.44	7.42	7.42	7.80	8.14
Month End Stock Price	6.52	11.19	11.37	19.29	21.14	16.66	14.35	23.51	27.11	25.34	22.78	19.69	24.19	25.34	20.99	22.78
Ratios	Annuals											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	Latest Q.	Sep11	Dec11	Mar12	Jun12	Sep12

Return on Equity %	-22.30	11.50	14.10	12.70	13.30	16.90	16.70	17.00	16.80	19.20	14.80	20.00	20.80	20.80	10.80	14.80
Return on Assets %	-11.60	4.70	6.00	6.00	6.50	7.00	6.70	8.00	7.80	6.40	5.20	8.40	7.60	6.80	3.60	5.20
Return on Capital - Joel Greenblatt %	12.10	18.00	19.40	22.00	23.70	24.10	26.50	29.60	31.90	31.50	19.60	35.60	31.20	34.00	15.20	19.60
Debt to Equity	0.34	0.77	0.63	0.43	0.40	0.66	0.82	0.46	0.44	1.18	1.13	0.62	0.82	1.18	1.17	1.13

Gross Margin %	28.50	28.50	28.70	28.90	28.70	29.20	29.80	30.50	31.20	32.10	33.80	32.00	32.30	32.60	33.30	33.80
Operating Margin %	2.20	3.50	4.20	4.50	4.70	5.00	5.20	5.90	6.60	6.30	6.40	7.00	6.60	6.70	5.20	6.40
Net Margin %	-4.60	2.00	2.60	2.70	2.90	3.10	3.00	3.40	3.70	3.50	3.60	3.80	3.80	3.70	2.60	3.60

Days Sales Outstanding	47.80	50.90	53.80	47.10	46.70	46.70	43.10	40.50	44.30	44.70	42.00	42.70	43.00	43.50	42.70	42.00
Days Inventory	34.60	37.80	46.60	55.00	51.20	53.00	55.30	56.00	55.60	54.60	54.10	58.90	66.30	53.50	58.10	54.10
Inventory Turnover	10.60	9.70	7.80	6.60	7.10	6.90	6.60	6.50	6.60	6.70	1.70	1.50	1.40	1.70	1.60	1.70

Debt to Revenue	0.07	0.14	0.12	0.09	0.09	0.12	0.15	0.09	0.10	0.22	1.09	0.48	0.61	0.84	1.12	1.09
COGS to Revenue	0.71	0.71	0.71	0.71	0.71	0.71	0.70	0.69	0.69	0.68	0.66	0.68	0.68	0.67	0.67	0.66
Inventory to Revenue	0.07	0.07	0.09	0.11	0.10	0.10	0.11	0.11	0.11	0.10	0.39	0.44	0.49	0.40	0.43	0.39
Interest Exp. to Revenue %	-0.79	-0.40	-0.45	-0.34	-0.24	-0.33	-0.49	-0.82	-0.83	-0.95	-2.03	-0.89	-0.91	-1.13	-2.07	-2.03

Asset Turnover	2.50	2.30	2.28	2.20	2.25	2.28	2.24	2.36	2.14	1.82	0.35	0.54	0.51	0.47	0.34	0.35
Buyback Ratio	1.50	-17.80	-14.10	-45.90	-33.60	-4.90	--	--	--	--	--	--	--	--	--	--
Income Statement	Annuals (USD $) View: $ %											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	TTM	Sep11	Dec11	Mar12	Jun12	Sep12

Revenue	1,178	1,350	1,474	1,619	1,742	1,856	1,953	2,055	2,035	2,102	1,897	522	528	539	409	421
Cost of Goods Sold	842	965	1,050	1,152	1,242	1,314	1,371	1,427	1,399	1,428	1,272	355	357	363	273	279
Gross Profit	336	385	423	467	500	542	582	628	636	674	625	167	170	176	136	142

Selling, General, &Admin. Expense	310	338	362	395	418	449	481	507	502	541	506	131	136	140	115	115
Earnings Before DDA	41.34	64.48	82.26	94.11	107	118	126	148	165	169	153	45.01	43.73	45.33	28.91	35.09

Depreciation, Depletion and Amortization	15.46	16.66	20.70	21.70	24.09	25.71	25.27	27.06	31.44	35.78	34.25	8.75	8.99	9.49	7.65	8.12

Operating Income	25.89	47.82	61.56	72.41	82.49	92.40	101	121	134	133	119	36.27	34.74	35.84	21.26	26.97
Interest Income/Expense	-9.31	-5.38	-6.64	-5.46	-4.15	-6.08	-9.54	-16.92	-16.84	-19.98	-27.91	-4.62	-4.80	-6.09	-8.49	-8.53
Net Income	-54.76	27.54	38.97	44.26	50.48	56.78	58.02	69.36	74.49	74.32	66.11	20.03	20.13	19.97	10.74	15.27

Earnings per Share ($)	-0.78	0.40	0.59	0.66	0.73	0.86	0.96	1.18	1.32	1.38	1.27	0.37	0.38	0.38	0.21	0.30
Total Shares Outstanding	70.37	67.99	65.61	67.06	69.33	66.18	60.70	58.94	56.55	53.99	50.07	53.96	52.44	52.18	50.26	50.07
Balance Sheet	Annuals (USD $) View: $ %											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	Latest Q.	Sep11	Dec11	Mar12	Jun12	Sep12

Cash and cash equivalents	19.17	58.93	17.89	23.87	46.66	21.12	92.62	52.75	29.35	163	122	34.85	32.44	163	107	122
Accounts Receivable	154	188	217	209	223	237	230	228	247	258	194	245	250	258	192	194
Inventory	79.75	99.86	134	173	174	191	208	219	213	214	166	229	260	214	174	166
Other Current Assets	43.68	49.50	48.47	46.79	43.21	59.23	31.88	42.11	54.82	51.25	334	50.60	58.99	51.25	332	334
Total Current Assets	297	397	418	453	487	508	562	542	545	686	816	559	601	686	806	816

Property, Plant and Equipment	61.34	69.59	81.11	87.66	88.63	90.68	100	105	102	101	84.01	100	102	101	83.41	84.01
Intangible Assets	66.91	81.20	107	140	137	137	136	146	209	256	195	214	235	256	194	195
Other Long Term Assets	46.63	39.34	39.96	56.37	62.45	78.71	73.53	78.86	95.69	113	117	90.80	101	113	111	117
Total Assets	472	587	646	737	775	815	872	872	952	1,156	1,212	965	1,039	1,156	1,194	1,212

Accounts Payable	118	124	155	174	169	182	180	174	165	188	168	193	206	188	181	168
Current Portion of Long-Term Debt	83.00	35.00	25.00	0.51	2.24	70.99	50.94	0.88	0.76	--	--	50.38	0.19	--	--	--
Other Current Liabilities	7.27	16.96	9.70	13.64	11.44	11.97	7.96	10.95	33.21	12.04	59.82	22.42	17.98	12.04	46.88	59.82
Total Current Liabilities	208	176	189	188	182	265	239	186	199	200	228	266	224	200	228	228

Long-Term Debt	--	150	150	151	151	151	232	188	196	455	460	200	319	455	457	460
Other Long-Term Liabilities	18.61	21.29	30.31	49.43	61.21	64.13	54.60	90.05	114	114	117	97.13	107	114	117	117
Total Liabilities	227	348	370	388	394	480	525	464	509	769	804	563	650	769	802	804

Common Stock	0.68	0.65	0.65	0.67	0.67	0.61	0.58	0.56	0.55	0.50	0.49	0.52	0.50	0.50	0.49	0.49
Retained Earnings	-81.07	-53.53	-14.56	29.70	80.18	137	195	245	319	387	407	354	374	387	392	407
Additional Paid-In Capital	326	292	292	321	300	196	149	162	123	--	--	47.20	14.85	--	--	--
Total Equity	245	239	277	349	381	335	347	408	443	387	408	401	389	387	392	408
Cashflow Statement	Annuals (USD $) View: $ %											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	TTM	Sep11	Dec11	Mar12	Jun12	Sep12

Net Income	-54.76	27.54	38.97	44.26	50.48	56.78	58.02	69.36	74.66	74.40	66.03	20.16	20.10	20.00	10.73	15.20
Depreciation, Depletion and Amortization	15.46	16.66	20.70	21.70	24.09	25.71	25.27	27.06	31.44	35.78	34.25	8.75	8.99	9.49	7.65	8.12
Cash Flow from Others	83.42	-22.33	-23.41	1.73	-11.03	-12.64	6.43	5.98	10.22	18.11	18.97	-6.24	-20.62	32.83	4.47	2.30
Cash Flow from Operations	44.11	21.86	36.26	67.69	63.54	69.85	89.72	102	116	128	119	22.67	8.47	62.32	22.85	25.61

Investment for Property, Plant & Equipement	-12.00	-21.12	-25.93	-17.01	-17.27	-19.26	-26.94	-25.92	-18.23	-23.92	-24.05	-6.21	-6.68	-6.34	-4.00	-7.03
Cash Flow from Acquisitions	-4.46	-19.33	-24.37	-37.60	-2.87	-15.25	-3.74	-14.80	-65.93	-65.13	-124	-10.08	-29.34	-25.50	-66.05	-2.69
Cash Flow from Investing	-6.57	-43.50	-63.47	-56.30	-21.29	-55.94	-8.80	-30.59	-88.11	-89.21	-149	-16.37	-36.13	-31.78	-71.37	-9.80

Net Issuance of Stock	-24.77	-35.74	-4.43	20.30	-25.94	-110	-52.77	-57.18	-54.76	-140	-67.28	-23.14	-34.86	-24.68	-7.47	-0.27
Net Issuance of Debt	-47.17	103	-9.40	-25.35	0.88	69.09	-0.51	-50.93	-0.83	250	200	29.29	66.07	134	--	--
Other Financing	0.00	-6.06	--	-0.37	5.60	1.20	33.28	7.01	3.97	-14.83	-15.78	0.11	-5.96	-9.47	0.26	-0.61
Cash Flow from Financing	-71.94	61.39	-13.83	-5.41	-19.46	-39.45	-20.01	-101	-51.63	94.73	117	6.26	25.25	100	-7.22	-0.88

Net Change in Cash	-34.40	39.76	-41.04	5.98	22.79	-25.54	60.91	-29.28	-23.40	134	87.50	12.56	-2.41	131	-55.74	14.94

Free Cash Flow	32.11	0.74	10.33	50.68	46.28	50.58	62.78	76.48	98.10	104	95.19	16.45	1.79	55.97	18.85	18.58
Valuation Ratios (Daily)	Annuals											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	Latest Q.	Sep11	Dec11	Mar12	Jun12	Sep12

PE Ratio(ttm)
Price to Tangible Book
Price-to-Free-Cash-Flow ratio
PS Ratio
EV-to-Revenue
EV-to-EBITDA
EV-to-EBIT
Earnings Yield (Joel Greenblatt)
Forward Rate of Return
Shiller PE Ratio
Valuation and Quality	Annuals											Semi-Annual
Fiscal Period	Mar03	Mar04	Mar05	Mar06	Mar07	Mar08	Mar09	Mar10	Mar11	Mar12	Latest Q.	Sep11	Dec11	Mar12	Jun12	Sep12

Market Cap
Enterprise Value
Month End Stock Price
Net Cash (per share)
Net Current Asset Value (per share)
DCF (per share)
Median PS (per share)
Peter Lynch Fair Value (per share)
Graham Number (per share)
Altman Z-Score
Piotroski F-Score
Beneish M-Score

Switch to Another Stock:

PSSI Quarterly/Annuals Reports

PSSI: 10-Q - PSS WORLD MEDICAL INC (0000920527) (Filer): (10-Q) - 2012-11-07
PSSI: 10-Q - PSS WORLD MEDICAL INC (0000920527) (Filer): (10-Q) - 2012-08-08
PSSI: 10-K - PSS WORLD MEDICAL INC (0000920527) (Filer): (10-K) - 2012-05-25
PSSI: 10-Q - PSS WORLD MEDICAL INC (0000920527) (Filer): (10-Q) - 2012-02-08
PSSI: 10-Q - PSS WORLD MEDICAL INC (0000920527) (Filer): (10-Q) - 2011-08-10

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

PSSI Quarterly/Annuals Reports